Seeding Biotech Investments Yielding Long-Term Success

See our investors section

The Largest Israeli Portfolio By Market Cap – Managing Over $600 Million In Capital

See our portfolio

Driven By Strategic Vision And Backed By Significant Financial Resources

See our profile
  • View Our New Investors Presentation

    See more





     
  • Andromeda – Trial Results Following Phase III of Diabetic Patients Treated with DiaPep277

    See more





     
  • Clal Biotechnology Intends on Participating in the Biocancell Issuing, Will Propose Purchasing Units up to NIS 16M (HEB)

    See more





     

company profile

cbi stock on tase

1,220
agorot
+- 54
agorot
+- 4,6%

Financial report